# FDA recall D-381-2014

> **Hospira Inc.** · Class I · drug recall initiated 2013-07-12.

## Product

0.75% Bupivacaine HCl Injection, USP, 7.5 mg/mL, 30 mL, Single-dose, Hospira Inc., Lake Forest, IL 60045, NDC 0409-1165-02

## Reason for recall

Presence of particulate matter: visible free floating and partially embedded particulate matter in the glass vials.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-381-2014
- **Recalling firm:** Hospira Inc.
- **Classification:** Class I
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-07-12
- **Report date:** 2013-12-25
- **Termination date:** 2015-02-03

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Lake Forest, IL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-381-2014

## Citation

> AI Analytics. FDA recall D-381-2014. Retrieved 2026-05-24 from https://api.ai-analytics.org/recall/D-381-2014. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*